Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 121Unknown 35Terminated 20Recruiting 5Active not recruiting 5Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Lymphoid 1Gastrointestinal 1CNS 1

Conditions

Vomiting 1Recurrence 1Pancreatic Neoplasms 1Nausea 1Multiple Myeloma 1Medulloblastoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Large Granular Lymphocytic 1Ependymoma 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × OTHER × Thalidomide × Clear all
NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting
232 enrolled
CNS

Ependymoma, Medulloblastoma, Recurrence

NCT06530576 2025-11-18

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting
48 enrolled
Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

NCT06017284 2023-11-24

PTCA199-5

Fudan University

Phase 3 Recruiting
100 enrolled
Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

NCT03980002 2019-06-10

BDHCLL001

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting
50 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03562169 2018-06-19

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

University of Leeds

Phase 3 Recruiting
406 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡